Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Oyster Point Pharma (OYST)
NASDAQ:OYST
RESEARCH TOOLSreports
Oyster Point Pharma (OYST) Financial Statements
0 Followers
Oyster Point Pharma Financial Overview
| Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 5.59M | $ 4.69M | $ 2.70M | $ 6.60M | $ 17.94M |
| Gross Profit | $ 4.24M | $ 3.38M | $ 2.37M | $ 5.07M | - |
| EBIT | $ -33.25M | $ -46.79M | $ -44.83M | $ -39.45M | $ -16.55M |
| EBITDA | $ -33.18M | $ -46.67M | $ -44.75M | $ -39.40M | $ -16.51M |
| Net Income Common Stockholders | $ -36.75M | $ -49.94M | $ -47.89M | $ -42.06M | $ -17.67M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 68.80M | $ 104.88M | $ 143.36M | $ 193.37M | $ 184.17M |
| Total Assets | $ 109.20M | $ 143.94M | $ 176.72M | $ 222.62M | $ 195.01M |
| Total Debt | $ 94.72M | $ 94.14M | $ 93.36M | $ 92.73M | $ 42.58M |
| Net Debt | $ 25.92M | $ -10.73M | $ -50.01M | $ -100.64M | $ -141.59M |
| Total Liabilities | $ 131.40M | $ 133.16M | $ 120.73M | $ 123.08M | $ 57.50M |
| Stockholders Equity | $ -22.20M | $ 10.78M | $ 55.99M | $ 99.54M | $ 137.51M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -35.97M | $ -38.95M | $ -49.79M | $ -41.71M | $ -11.07M |
| Operating Cash Flow | $ -35.97M | $ -38.83M | $ -49.70M | $ -41.48M | $ -10.81M |
| Investing Cash Flow | $ 0.00 | $ -118.00K | $ -85.00K | $ -235.00K | $ -256.00K |
| Financing Cash Flow | $ -166.00K | $ 460.00K | $ -218.00K | $ 50.92M | $ 40.43M |
Oyster Point Pharma Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.